Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 2018

View Archived Issues

Shionogi reviews highlights of third quarter of fiscal 2017

MSK1 shown as a new prognostic biomarker in ER+ breast cancer

Novel multifunctional vehicle strategy for delivering Cas9-sgRNAs into tumor cells

Takeda updates clinical progress of third quarter of fiscal 2017

INSERM and collaborators patent stromal cell-derived factor 1 inhibitors

Bayer divulges novel TASK-1/3 blockers

Ensoltek describes new peptides acting as RAGE receptor ligands

Advanced Proteome Therapeutics and ImmunoBiochem to collaborate on antibody-drug conjugates

Iovance Biotherapeutics discloses new PD-L1 binding proteins

Bexsero receives second breakthrough therapy designation from the FDA

Novel monoclonal antibodies targeting VE-PTP synthesized at Aerpio Pharmaceuticals

Novel influenza vaccine induces robust long-lasting immunity in mice

Amgen reports product advances for 2017

Ono Pharmaceutical updates key events of third quarter of fiscal 2017

Janssen describes characterization of clinical candidate P2X7 antagonist for mood disorders

Top-line results for ACTION 2 study of natalizumab in acute ischemic stroke

Researchers present phase II data from NabucCO trial on metastatic pancreatic cancer

Verastem submits NDA for duvelisib

FDA approves Biktarvy to treat HIV-1 infection

Case Western, Sangamo awarded grant to advance research on gene-edited T cells to treat HIV

Xcovery starts phase II trial for ensartinib in melanoma patients with ALK alterations

Sage Therapeutics' SAGE-217 given FDA breakthrough therapy designation for major depressive disorder

Aviragen and Vaxart agree to amend merger agreement

YL Biologics reports successful completion of phase III trial of etanercept biosimilar YLB-113

Silenseed initiates phase II study of siG12D LODER in locally advanced pancreatic cancer

Insmed studies INS-1007 in phase II for non-cystic fibrosis bronchiectasis

Symic Biomedical reports MODIFY2 phase II trial results of SB-061 for knee osteoarthritis

GlaxoSmithKline initiates first-in-human study of GSK-2983559

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...